Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)
Compose a Response to This Article
Other responses
No responses have been published for this article.
